Active Shortage Injection Antiviral
Peginterferon alfa-2a Inject · 595 days since initial FDA posting
Brand: PEGASYS
FDA lists Peginterferon alfa-2a Inject as Active Shortage (pharmaand GmbH (pharma&)).
Availability on file: Limited Availability
Peginterferon alfa-2a Injection: Active Shortage
Limited Availability Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Peginterferon alfa-2a Injection
- Manufacturer
- pharmaand GmbH (pharma&)
- Dosage Form
- Injection
- Presentation
- Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1)
- Package NDC
- 82154-0449-1
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Jan 24, 2025
- Last Updated
- Aug 19, 2025
- Therapeutic Category
- Antiviral
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Pegasys availability will become more limited through Q4 2025. Product replenishment is expected sometime in 2026 and before May 31, 2026.
Nearby, Other Peginterferon Shortage Records
FDA reason on file: Pegasys availability will become more limited through Q4 2025. General shortage guidance lives on the tracker hub.